Argenica Therapeutics Revenue

Argenica Therapeutics had revenue of 2.83M AUD in the half year ending December 31, 2024, with 105.66% growth. This brings the company's revenue in the last twelve months to 3.08M, up 13.03% year-over-year. In the fiscal year ending June 30, 2024, Argenica Therapeutics had annual revenue of 2.60M with 48.46% growth.

Revenue (ttm)

3.08M

Revenue Growth

+13.03%

P/S Ratio

26.62

Revenue / Employee

n/a

Employees

n/a

Market Cap

81.98M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	2.60M	848.04K	48.46%
Jun 30, 2023	1.75M	1.49M	575.38%
Jun 30, 2022	259.10K	-36.98K	-12.49%
Jun 30, 2021	296.08K	-	-
Jun 30, 2020	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CSL Limited	24.61B
Pro Medicus	184.58M
Cochlear	2.31B
Sonic Healthcare	9.33B
Telix Pharmaceuticals	783.21M
Ramsay Health Care	17.12B
Ansell	3.00B
Mesoblast	9.16M

Revenue Rankings